Skip to content

Hexocyclium

Tral (hexocyclium) is a small molecule pharmaceutical. Hexocyclium was first approved as Tral on 1982-01-01. It is known to target muscarinic acetylcholine receptor M3, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M1.
Trade Name Tral
Common Name Hexocyclium
Indication
Drug Class Quaternary ammonium derivatives
Hexocyclium
Get full access now